Valuation: Safe Fertility Group

Market Cap 1.64B 49.55M 42.8M 40.21M 36.57M 68.76M 4.74B 69.89M 471M 184M 2.37B 186M 182M 7.88B P/E 2026 *
12.9x
P/E 2027 * 11.6x
Enterprise Value 1.64B 49.55M 42.8M 40.21M 36.57M 68.76M 4.74B 69.89M 471M 184M 2.37B 186M 182M 7.88B EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.13x
Free-Float
23.1%
Yield 2026 *
6.85%
Yield 2027 * 7.41%
08-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-20 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-18 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 22, 2026 CI
11-06 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-06 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-29 Safe Fertility Group Public Company Limited Approves Dividend for the Year 2024, Payable on 23 May 2025 CI
25-02-19 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-02-19 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 23, 2025 CI
24-11-06 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-11-01 125,378,468 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-NOV-2024. CI
24-08-06 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
1 day+0.93%
1 month-5.26%
3 months-8.47%
6 months-15.62%
Current year-14.96%
1 week 5.35
Extreme 5.35
5.45
1 month 5.35
Extreme 5.35
5.8
Current year 5.35
Extreme 5.35
6.9
1 year 5.35
Extreme 5.35
7.95
3 years 5.35
Extreme 5.35
23.7
5 years 5.35
Extreme 5.35
23.7
10 years 5.35
Extreme 5.35
23.7
Manager TitleAgeSince
Chief Executive Officer 60 2006-12-31
Director of Finance/CFO 45 -
Chief Operating Officer 59 2009-07-19
Director TitleAgeSince
Director/Board Member 60 2006-12-31
Director/Board Member 59 2009-07-19
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap.
1/20/26 Buy

Chief Executive Officer

10,000 0.0033%
1/19/26 Buy

Chief Executive Officer

62,000 0.0204%
1/12/26 Buy

Chief Executive Officer

27,500 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
+0.93%0.00%-28.00% - 49.55M
+2.28%+1.53%+41.63%+32.50% 124B
-1.71%-2.10%+2.25%+50.57% 87.61B
-1.22%+0.04%+2.33%+56.99% 30.7B
-0.69%-1.66%+30.39%+75.54% 25.87B
+0.32%+2.20%+55.74%+267.39% 21.57B
+0.96%-1.62%-9.21%-13.31% 21.29B
-2.55%-0.77%-10.31%+9.46% 14.02B
+0.12%-2.40%-3.73%-9.60% 12.59B
+0.50%-2.02%+33.00%+71.16% 11.48B
Average -0.11%-0.28%+11.41%+60.08% 34.95B
Weighted average by Cap. +0.22%+0.48%+21.23%+52.91%

Financials

2026 *2027 *
Net sales 698M 21.07M 18.2M 17.1M 15.55M 29.24M 2.01B 29.72M 200M 78.35M 1.01B 79.11M 77.4M 3.35B 772M 23.31M 20.13M 18.91M 17.2M 32.34M 2.23B 32.87M 222M 86.65M 1.12B 87.5M 85.6M 3.71B
Net income 128M 3.86M 3.34M 3.14M 2.85M 5.36M 369M 5.45M 36.75M 14.37M 185M 14.51M 14.19M 615M 142M 4.27M 3.69M 3.47M 3.15M 5.93M 408M 6.03M 40.62M 15.88M 205M 16.04M 15.69M 680M
Net Debt - -
Logo Safe Fertility Group
Safe Fertility Group Public Company Limited is a Thailand-based company engaged in providing an obstetrics and gynecology hospital. It is also engaged in the business of medical laboratory and cosmetic dermatology. The Company's segments are Obstetrics and Gynecology Hospital and Medical Laboratory, and Cosmetic Dermatology. Its services categories include In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI), Intrauterine Insemination (IUI), Egg Freezing, Embryo Transfer, Sperm Freezing, Sperm Analysis, Magnetic Activated Cell Sorting (MACS) Sperm, Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Testicular Sperm Extraction/Percutaneous Epididymal Sperm Aspiration (TESE/PESA), Couple Check-Up, EmbryoScope Plus, Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic Disorders (PGT-M), and Acupuncture. The Company's subsidiaries include Next Generation Genomics Co., Ltd., and Safe Wellness Company Limited.
Employees
-
Date Price Change Volume
26-08-14 THB 5.400 +0.93% 164,700
26-08-13 THB 5.350 0.00% 611,900
26-08-11 THB 5.350 -0.93% 242,700
26-08-10 THB 5.400 0.00% 211,224
26-08-07 THB 5.400 0.00% 352,900
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.400THB
Average target price
7.525THB
Spread / Average Target
+39.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SAFE Stock